INDICATION-SPECIFIC PRICING OF PHARMACEUTICALS IN THE UNITED STATES HEALTH CARE SYSTEM

whitePaper | January 21, 2023

As a consequence of widespread consolidation of buying power within integrated healthcare networks (IHNs), Pharma, Medical Device, and Biotech sales and marketing teams are facing information gaps that threaten their sales growth if left unaddressed.

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

whitePaper | September 12, 2022

While informed consent is a critical process for ensuring participant autonomy in clinical research, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels.

whitePaper | November 12, 2022

The past two years have seen accelerated adoption and utilization of telehealth services by a majority of healthcare organizations, driven in large part by the COVID-19 pandemic.

whitePaper | February 23, 2022

Currently, no federal law protects consumers against “surprise” bills from out-of-network ground ambulance providers. Some state and local governments regulate ground ambulance surprise billing practices.

whitePaper | March 19, 2023

The pressure on healthcare systems to deliver more services with fewer resources is highly significant. These pressures are now manifesting in emerging signals of change that are shaping how healthcare will be delivered and consumed in the future.